Clinical Trials Directory

Trials / Completed

CompletedNCT06284928

Metagenomic Analysis of Gut Microbiota in Untreated and Uncontrolled Hypertensive Patients

Exploration of Microbial Patterns in Hypertension: A Cross-Sectional Analysis of Gut Microbiota in Newly Diagnosed Patients (MIPHYP-CROSS Study)

Status
Completed
Phase
Study type
Observational
Enrollment
192 (actual)
Sponsor
Xinjiang Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This observational study aims to explore the relationship between gut microbiota composition and blood pressure regulation in patients with hypertension. A total of 192 participants will be enrolled, including newly diagnosed untreated hypertensive patients, patients with uncontrolled hypertension under medication, and healthy controls. Fecal samples will be collected for metagenomic sequencing to identify microbial taxa and functional pathways associated with blood pressure levels. The findings are expected to reveal characteristic microbial patterns linked to hypertension and provide potential microbial targets for improving antihypertensive therapy.

Conditions

Interventions

TypeNameDescription
OTHERFecal Sample CollectionNon-invasive stool sample collection for gut microbiota metagenomic analysis. No drug or behavioral intervention involved.

Timeline

Start date
2019-12-01
Primary completion
2020-06-01
Completion
2020-12-01
First posted
2024-02-29
Last updated
2026-01-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06284928. Inclusion in this directory is not an endorsement.

Metagenomic Analysis of Gut Microbiota in Untreated and Uncontrolled Hypertensive Patients (NCT06284928) · Clinical Trials Directory